These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 19545630)

  • 21. Safety and immunogenicity of oral killed whole cell recombinant B subunit cholera vaccine in Barranquilla, Colombia.
    Concha A; Giraldo A; Castañeda E; Martínez M; de la Hoz F; Rivas F; Depetris A; Svennerholm AM; Sack DA
    Bull Pan Am Health Organ; 1995 Dec; 29(4):312-21. PubMed ID: 8605522
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intranasal immunization of a DNA vaccine with IL-12- and granulocyte-macrophage colony-stimulating factor (GM-CSF)-expressing plasmids in liposomes induces strong mucosal and cell-mediated immune responses against HIV-1 antigens.
    Okada E; Sasaki S; Ishii N; Aoki I; Yasuda T; Nishioka K; Fukushima J; Miyazaki J; Wahren B; Okuda K
    J Immunol; 1997 Oct; 159(7):3638-47. PubMed ID: 9317164
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Intranasal immunization with mucosal complex vaccine protects mice against Toxoplasma gondii].
    Yin GR; Meng XL; Ma GY; Ma XM
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2007 Aug; 25(4):290-4. PubMed ID: 18038798
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nanocochleates containing N-Octylglicoside extracted Vibrio cholerae antigens elicited high vibriocidal antibodies titers after intragastric immunization in a mice model.
    Tamargo SB; Bui Thanh T; Pérez M; Otero O; Oliva HR; Falero G; Pérez JL; Cedré MB; Okuskhanova E; Thiruvengadam M; Shariati MA; Sierra GVG
    Microb Pathog; 2021 Jul; 156():104902. PubMed ID: 33930421
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pilot scale production of the vaccine adjuvant Proteoliposome derived Cochleates (AFCo1) from Neisseria meningitidis serogroup B.
    Zayas C; González D; Acevedo R; del Campo J; Lastre M; González E; Romeu B; Cuello M; Balboa J; Cabrera O; Guilherme L; Pérez O
    BMC Immunol; 2013; 14 Suppl 1(Suppl 1):S4. PubMed ID: 23458578
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Proteliposome-derived Cochleate as an immunomodulator for nasal vaccine.
    Pérez O; Bracho G; Lastre M; Zayas C; González D; Gil D; del Campo J; Acevedo R; Taboada C; Rodríguez T; Fajardo ME; Sierra G; Campa C; Mora N; Barberá R; Solís RL
    Vaccine; 2006 Apr; 24 Suppl 2():S2-52-3. PubMed ID: 16823925
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunomodulatory effects of mesenchymal stem cell-conditioned media on lipopolysaccharide of Vibrio cholerae as a vaccine candidate.
    Bahroudi M; Bakhshi B; Soudi S; Najar-Peerayeh S
    Stem Cell Res Ther; 2021 Nov; 12(1):564. PubMed ID: 34732259
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunological evaluation of bacterial derived Cochleate and proteoliposome as mucosal adjuvants.
    del Campo J; Lastre M; Bracho G; Rodríguez T; Gil D; Zayas C; Taboada C; Acevedo R; Pérez DR; Pérez O
    Vaccine; 2006 Apr; 24 Suppl 2():S2-50-1. PubMed ID: 16823924
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vibrio cholerae lipopolysaccharide loaded chitosan nanoparticle could save life by induction of specific immunoglobulin isotype.
    Fasihi-Ramandi M; Ghobadi-Ghadikolaee H; Ahmadi-Renani S; Taheri RA; Ahmadi K
    Artif Cells Nanomed Biotechnol; 2018 Feb; 46(1):56-61. PubMed ID: 28278575
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of a MAIT-Activating Ligand, 5-OP-RU, as a Mucosal Adjuvant in a Murine Model of
    Jensen O; Trivedi S; Li K; Aubé J; Hale JS; Ryan ET; Leung DT
    Pathog Immun; 2022; 7(1):122-144. PubMed ID: 36072570
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Proteoliposome derived cochleate as novel adjuvant.
    Bracho G; Lastre M; del Campo J; Zayas C; González D; Gil D; Acevedo R; Taboada C; Solís RL; Pérez O
    Vaccine; 2006 Apr; 24 Suppl 2():S2-30-1. PubMed ID: 16823914
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Scale up of proteoliposome derived Cochleate production.
    Zayas C; Bracho G; Lastre M; González D; Gil D; Acevedo R; del Campo J; Taboada C; Solís RL; Barberá R; Pérez O
    Vaccine; 2006 Apr; 24 Suppl 2():S2-94-5. PubMed ID: 16823944
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Erratum to: Use of a MAIT-Activating Ligand, 5-OP-RU, as a Mucosal Adjuvant in a Murine Model of
    Jensen O; Trivedi S; Cacioppo JG; Li K; Aubé J; Hale JS; Ryan ET; Leung DT
    Pathog Immun; 2022; 7(1):145-146. PubMed ID: 36147447
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effectiveness of a proteoliposome-based vaccine against salmonid rickettsial septicaemia in Oncorhynchus mykiss.
    Caruffo M; Vidal S; Santis L; Siel D; Pérez O; Huenchullan PR; Sáenz L
    Vet Res; 2021 Aug; 52(1):111. PubMed ID: 34425904
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immune adjuvant effect of V. cholerae O1 derived Proteoliposome coadministered by intranasal route with Vi polysaccharide from Salmonella Typhi.
    Acevedo R; Callicó A; Aranguren Y; Zayas C; Valdés Y; Pérez O; García L; Ferro VA; Pérez JL
    BMC Immunol; 2013; 14 Suppl 1(Suppl 1):S10. PubMed ID: 23458379
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cochleates derived from Vibrio cholerae O1 proteoliposomes: the impact of structure transformation on mucosal immunisation.
    Acevedo R; Pérez O; Zayas C; Pérez JL; Callicó A; Cedré B; García L; Mckee D; Mullen AB; Ferro VA
    PLoS One; 2012; 7(10):e46461. PubMed ID: 23077508
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mucosal immunization with liposome-nucleic acid adjuvants generates effective humoral and cellular immunity.
    Henderson A; Propst K; Kedl R; Dow S
    Vaccine; 2011 Jul; 29(32):5304-12. PubMed ID: 21600950
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lipid complexes with cationic peptides and OAKs; their role in antimicrobial action and in the delivery of antimicrobial agents.
    Epand RF; Mor A; Epand RM
    Cell Mol Life Sci; 2011 Jul; 68(13):2177-88. PubMed ID: 21573783
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vibrio cholerae: lessons for mucosal vaccine design.
    Bishop AL; Camilli A
    Expert Rev Vaccines; 2011 Jan; 10(1):79-94. PubMed ID: 21162623
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intranasal administration of proteoliposome-derived cochleates from Vibrio cholerae O1 induce mucosal and systemic immune responses in mice.
    Acevedo R; Callicó A; del Campo J; González E; Cedré B; González L; Romeu B; Zayas C; Lastre M; Fernández S; Oliva R; García L; Pérez JL; Pérez O
    Methods; 2009 Dec; 49(4):309-15. PubMed ID: 19545630
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.